Conversion therapy for inoperable advanced gastric cancer patients by docetaxel, cisplatin, and S-1 (DCS) chemotherapy: a multi-institutional retrospective study

Yasushi Sato,Hiroyuki Ohnuma,Takayuki Nobuoka,Masahiro Hirakawa,Tamotsu Sagawa,Koshi Fujikawa,Yasuo Takahashi,Minami Shinya,Shinich Katsuki,Minoru Takahashi,Masahiro Maeda,Yutaka Okagawa,Uemura Naoki, Syouhei Kikuch,Koichi Okamoto,Hiroshi Miyamoto,Mitsuo Shimada,Takemasa Ichiro,Junji Kato,Tetsuji Takayama

Gastric Cancer（2017）

引用 58|浏览0

暂无评分

摘要

Conversion therapy is an option for unresectable metastatic gastric cancer when distant metastases are controlled by chemotherapy; however, the feasibility and efficacy remain unclear. This study aimed to assess the feasibility and efficacy of conversion therapy in patients with initially unresectable gastric cancer treated with docetaxel, cisplatin, and S-1 (DCS) chemotherapy by evaluating clinical outcomes.

查看译文

关键词

Gastric cancer,Conversion therapy,DCS

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要